Global Stem Cell Umbilical Cord Blood Market size was valued nearly US$ XX Bn. in 2019 and the total revenue is expected to grow at XX % through 2019 to 2027, reaching nearly US$ 10.02 Bn.
The report study has analyzed the revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers, and market disrupters in the report, and the same is reflected in our analysis.
Umbilical cord blood is a rich basis of hematopoietic stem cells capable of treating over 80 genetic diseases. Stem cells can also fight long-lasting illnesses like cancer, diabetes, blood disorders and immune diseases. While a small amount of cord blood can be achieved from a single umbilical cord, it comprises a large number of stem cells that can be advanced and stored for forthcoming use.
REQUEST FOR FREE SAMPLE REPORT: https://www.maximizemarketresearch.com/request-sample/72065
The global market for stem cell umbilical cord blood is expected to gain market growth from 2019 to 2027 because of the growing prevalence of chronic diseases coupled with the developing field of regenerative medicines globally. Also, many government associations and enterprises are supporting the growth of the stem cell umbilical cord blood market. However, competition in the stem cell umbilical cord blood market is intense with key players trying to create brand awareness and market companies are also adopting various market-based strategies.
In the U.S., most of the market share is with the three major companies such as Cryo-Cell, Cord Blood Registry (CBR), and ViaCord. The Cord Blood Registry (CBR) has been traded twice, once in 2015 to AMAG Pharmaceuticals for US$ 700 Mn. and again in 2018 to GI Partners for US$ 530 Mn. In Sept 2019, Cord Blood Registry also bought Nateras Evercord Cord Blood Banking business.
Within China, the government controls the industry by allowing only one cord blood bank to drive within each province and authorized government support, and permits are needed. Significantly, the government in China announced in late 2019 that it would be distributing new licenses for the first time, growing from the existing 7 licensed regions for cord blood banking to over 19 regions, with Beijing.
The MMR report will also provide an accurate prediction of the contribution of the various segments to the growth of the stem cell umbilical cord blood market size. Based on the storage services, the private cord blood banks segment expected to grow at the highest XX.06% CAGR during the forecast period thanks to technological developments done at the storage services. Also, by application, regenerative medicine is expected to grow at the highest CAGR of XX.15% and is expected to reach a value of US$ XX Mn. by 2027. This is attributed to regenerative medicines in organ transplant to remove the use of immune-suppressing medicines and anti-inflammatory action that are necessary to treat artificial tissues, organ, and bone.
North America stem cell umbilical cord blood market was valued US$ XX Mn. in 2019 and is expected to reach a value of US$ XX Mn. by 2027, with a CAGR of XX.20% during the forecast period. This is because of well-developed healthcare sectors, the presence of leading medical diagnostics companies, and the rising number of patients suffering from blood disorders and cancer. Europe accounts for the second-highest revenue share contribution to the global cord blood stem cells market followed by markets in Latin America, Asia Pacific and the Middle East & Africa respectively. Europe accounts for the second highest revenue share followed by markets in South America, APAC and MEA respectively.
In recent years, major players in the stem cell umbilical cord blood market have taken several strategic measures, like facility expansions and partnerships. Such as, in 2017, Vita34 Company (Germany) acquired German Company Seracell Pharma to support its position in the German market globally.
The MMR reports cover key developments in the stem cell umbilical cord blood market as organic and inorganic growth strategies. For example, in 2018, LifeCell Company, Indias prominent provider of preventive healthcare industry, launched new television commercial to make people conscious about cord stem cells banking.
The objective of the report is to present a comprehensive analysis of the Global Stem Cell Umbilical Cord Blood Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.The report also helps in understanding Global Stem Cell Umbilical Cord Blood Market dynamics, structure by analyzing the market segments and projects the Global Stem Cell Umbilical Cord Blood Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Stem Cell Umbilical Cord Blood Market make the report investors guide.
DO INQUIRY BEFORE PURCHASING REPORT HERE: https://www.maximizemarketresearch.com/inquiry-before-buying/72065
Scope of the Global Stem Cell Umbilical Cord Blood Market
Global Stem Cell Umbilical Cord Blood Market, By Storage services
Public Cord Blood Banks Private Cord Blood Banks Hybrid Cord Blood BanksGlobal Stem Cell Umbilical Cord Blood Market, By Therapeutics
Cancer Diabetes Blood Diseases Immune Disorders Metabolic Disorders OthersGlobal Stem Cell Umbilical Cord Blood Market, By Application
Transplant Medicine Regenerative MedicineGlobal Stem Cell Umbilical Cord Blood Market, By Region
North Americao USAo Canada Europeo UKo Franceo Germanyo Italyo Spaino Norwayo Russia Asia Pacifico Chinao Indiao Japano South Koreao Australiao Malaysiao Indonesiao Vietnam South Americao Mexicoo Brazilo Argentina Middle East and Africao GCC Countrieso South Africao Nigeriao EgyptKey players operating in the Global Stem Cell Umbilical Cord Blood Market
Cordlife Group Limited Regrow Biosciences Pvt. Ltd. Cord Blood America Cryo-Cell International Medipost Americord Registry Esperite China Cord Blood Corporation LifeCell Inetrnational ViaCord Takara Bio Europe AB Vita34 AG Smart Cells International Ltd. CBR Systems, Inc. Lifeforce Cryobanks
MAJOR TOC OF THE REPORT
Chapter One: Stem Cell Umbilical Cord Blood Market Overview
Chapter Two: Manufacturers Profiles
Chapter Three: Global Stem Cell Umbilical Cord Blood Market Competition, by Players
Chapter Four: Global Stem Cell Umbilical Cord Blood Market Size by Regions
Chapter Five: North America Stem Cell Umbilical Cord Blood Revenue by Countries
Chapter Six: Europe Stem Cell Umbilical Cord Blood Revenue by Countries
Chapter Seven: Asia-Pacific Stem Cell Umbilical Cord Blood Revenue by Countries
Chapter Eight: South America Stem Cell Umbilical Cord Blood Revenue by Countries
Chapter Nine: Middle East and Africa Revenue Stem Cell Umbilical Cord Blood by Countries
Chapter Ten: Global Stem Cell Umbilical Cord Blood Market Segment by Type
Chapter Eleven: Global Stem Cell Umbilical Cord Blood Market Segment by Application
Chapter Twelve: Global Stem Cell Umbilical Cord Blood Market Size Forecast (2019-2026)
Browse Full Report with Facts and Figures of Stem Cell Umbilical Cord Blood Market Report at: https://www.maximizemarketresearch.com/market-report/global-stem-cell-umbilical-cord-blood-market/72065/
About Us:
Maximize Market Research provides B2B and B2C market research on 20,000 high growth emerging technologies & opportunities in Chemical, Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.
Contact info:
Name: Vikas Godage
Organization: MAXIMIZE MARKET RESEARCH PVT. LTD.
Email: sales@maximizemarketresearch.com
Contact: +919607065656/ +919607195908
Website:www.maximizemarketresearch.com
More:
- Embattled Cordlife receives letter of demand from client for breach of contract - The Straits Times - May 4th, 2024
- From Cord Blood to Microbiome; The evolution of Rotary's gift to the people of WA - Lifeblood - May 2nd, 2024
- Efficacy and safety of human umbilical cord-derived mesenchymal stem cells in the treatment of refractory immune ... - Nature.com - April 28th, 2024
- Hitting the pavement for cord blood research | Cranbourne Star News - Cranbourne Star News - April 28th, 2024
- One year to test 200 Cordlife samples 'totally unjustified': Global cord blood banking experts - The Straits Times - April 15th, 2024
- Clinical trial: First cardiac bioimplants for treatment of myocardial infarction using umbilical cord stem cells - Medical Xpress - April 7th, 2024
- The umbilical cord: a rich and ethical stem cell source to advance ... - March 30th, 2024
- Story of discovery: getting a Notch up on cord blood cell ... - March 30th, 2024
- Cord Blood Transplants | Memorial Sloan Kettering Cancer Center - March 30th, 2024
- Therapeutic effect and study of human umbilical cord blood mononuclear cells in patients with ischaemic bowel ... - Nature.com - March 17th, 2024
- Global Cord Blood & Tissue Banking Industry Report 2024: The Vast Majority of the Global Cord Blood Market is Now ... - PR Newswire - March 15th, 2024
- Improving Transplant Outcomes and Cell Therapy Approaches - RegMedNet - March 9th, 2024
- The inhibition of ADAM17 in cord blood stem cell-derived CD16+ NK cells to enhance their cytotoxicity against acute ... - ScienceDirect.com - March 1st, 2024
- Beating Blood Cancer through Recycling - a Community crowdfunding project in Liverpool by Kate Williams - Crowdfunder UK - February 24th, 2024
- Cord Blood Registry (CBR ) by CooperSurgical and Fulgent Genetics Launch Innovative Genetic Testing - Investing.com Canada - February 9th, 2024
- Young cancer patient with 'no hope' of recovery saved by baby's umbilical cord - Study Finds - February 9th, 2024
- Global Cord Blood & Tissue Banking Industry Report 2024 - The Vast Majority of the Global Cord Blood Market is Now ... - ACROFAN - January 26th, 2024
- Finding the optimal combination of anticancer drug administration for the conditioning of cord blood transplantation - Medical Xpress - January 26th, 2024
- Cord Blood Banking Market Sales and Revenue Report 2023-2032 - WhaTech Technology and Markets News - January 26th, 2024
- Global Cord Blood & Tissue Banking Industry Report 2024 - The Vast Majority of the Global Cord Blood Market is Now ... - ACROFAN USA - January 24th, 2024
- Global Biobanking Market Size To Exceed USD 97.5 Billion By 2032 | CAGR of 5.8% - GlobeNewswire - January 24th, 2024
- The use of cryopreservation in life saving research - The Manufacturer - January 24th, 2024
- CD19-targeted CAR NK cell therapy achieves promising one-year results in patients with B-cell malignancies - Medical Xpress - January 18th, 2024
- Cord blood banking comes at a high cost to babies - STAT - STAT - January 18th, 2024
- Global Cord Blood and Tissue Banking Industry Gains Traction Amidst Surging M&A Activity and Technological Advances - PR Newswire - January 16th, 2024
- Donating Bone Marrow and Stem Cells: The Process and What To Expect - On Cancer - Memorial Sloan Kettering - January 11th, 2024
- Ask the doctors: Research being conducted on using stem cells to treat diabetes - The Spokesman Review - January 4th, 2024
- askST: Can cord blood units be transferred from one bank to another? - The Straits Times - December 27th, 2023
- Timeline: Cordlife's mishandling of cord blood units in Singapore - CNA - December 15th, 2023
- Next-Level Evolution: Enhancing the Human Body With Anthrobots ... - Securities.io - December 5th, 2023
- Fred Hutch at ASH: Gene therapies for sickle cell, how to improve ... - Fred Hutchinson Cancer Center - December 5th, 2023
- Enhancing the immunosuppressive properties of human umbilical ... - Phys.org - December 1st, 2023
- Global Status and Trends for Thromboangiitis Obliterans | JPR - Dove Medical Press - December 1st, 2023
- Early Stage Cell Therapy Trial Shows Promise in Treating Progressive Multiple Sclerosis - University of Colorado Anschutz Medical Campus - December 1st, 2023
- Global Medical Specialty Bag Market is Expected to Reach US$ 9.4 Billion by 2034, Rising at a Steady 4.7% CAGR | Future Market Insights, Inc. - Yahoo... - November 29th, 2023
- Repeated concussions can alter heart activity and impact the heart ... - Philippine Canadian Inquirer - November 29th, 2023
- Vita 34 increases revenue and earnings in Q3 2023 and further ... - PharmiWeb.com - November 27th, 2023
- Vita 34 increases revenue and earnings in Q3 2023 and further ... - Marketscreener.com - November 25th, 2023
- FY 2021 VA-Funded Projects - VA's Office of Research and Development - November 25th, 2023
- New study aims to expand access to stem cell transplant using ... - Healio - November 23rd, 2023
- Impact of GVHD Prophylaxis on CMV Reactivation and Disease ... - Cancer Network - November 23rd, 2023
- The Top 25 Women Leaders in Biotechnology of 2023 - The Healthcare Technology Report. - November 21st, 2023
- First Edition: November 20, 2023 - KFF Health News - November 21st, 2023
- An essential guide to the building blocks of life - Gates Notes - November 21st, 2023
- A Simple Way to Save Premature Babies - The New York Times - November 19th, 2023
- Perspectives of current understanding and therapeutics of Diamond ... - Nature.com - November 17th, 2023
- Brain Organoids: Should They Be Considered People? - BBVA OpenMind - November 17th, 2023
- Understanding the cause of childhood Alzheimer's - ASBMB Today - November 17th, 2023
- Peripheral nerve regeneration through nanofiber scaffolds | IJN - Dove Medical Press - November 15th, 2023
- Are STEM CELL EXOSOMES the secret to a 'snatched' jawline? Discover the products that influencers are claiming - Daily Mail - November 13th, 2023
- CAR-NK: The next generation in hematological malignancy treatment - News-Medical.Net - November 13th, 2023
- Regenerative Medicine | Top Regenerative Medicine Solution ... - Healthcare Tech Outlook - November 13th, 2023
- Stem cell therapy, emerging solution to slow down ageing - Punch Newspapers - November 13th, 2023
- Improving Cord Blood Transplantation Outcomes for Adults With ... - On Cancer - Memorial Sloan Kettering - November 11th, 2023
- 8 Ways To Save Lives With Canadian Blood Services & You Can ... - Narcity Canada - November 11th, 2023
- Internal investigation by Vita 34 AG reveals irregularities related to a ... - Marketscreener.com - November 11th, 2023
- 'We worried the worst would happen' - Yorkshire Children's Trust ... - The Yorkshire Post - November 11th, 2023
- Minor GPI(-) granulocyte populations in aplastic anemia and healthy ... - Nature.com - November 9th, 2023
- Repeated treatment with ProTrans is immunologically safe ... - Marketscreener.com - November 7th, 2023
- Affimed Announces Oral Presentation of Phase 1/2 Data from AFM13 in Combination with Allogeneic NK Cells - Benzinga - November 7th, 2023
- Health Canada issues warning on cord blood stored in Edmonton - CBC News - November 3rd, 2023
- Affimed Announces Oral Presentation of Phase 1/2 Data from AFM13 in Combination with Allogeneic NK Cells at the 2023 ASH Annual Meeting - Yahoo... - November 3rd, 2023
- Dynamic Stem Cell Therapy Uncovers Research in Advance ... - InvestorsObserver - November 3rd, 2023
- Go with the flow and achieve hearing restoration - Drug Discovery News - November 3rd, 2023
- Cell Therapy Market to Witness Exponential Growth by 2031 ... - Argyle Report - November 1st, 2023
- Cross-talk between Myeloid and B Cells Shapes the Distinct ... - Cancer Discovery - November 1st, 2023
- Comparison of effects of HucMSCs, exosomes, and conditioned ... - Nature.com - October 28th, 2023
- The structural and functional complexity of the integrative ... - Science - October 28th, 2023
- Global Primary Cells Market to Witness Growth at 11.41% CAGR to ... - GlobeNewswire - October 26th, 2023
- Hma-Qubec celebrates 25 years of giving life in anniversary ad - - The Message - October 26th, 2023
- Improvement of thermal-stability of chondroitinase ABCI immobilized ... - Nature.com - October 26th, 2023
- Sydney Couple Overcomes Sperm Antibody Issue to Welcome Baby - OPP.Today - October 24th, 2023
- New Research Reveals Surprising Issue with Sperm and Fertility - CityLife - October 24th, 2023
- Biobanking Market to Observe Prominent CAGR of 6.10% by 2029 ... - PharmiWeb.com - October 21st, 2023
- TV shows like BBC's Call The Midwife and C4's One Born Every Minute 'are inaccurately depicting childbirth' an - Daily Mail - October 19th, 2023
- Advances in medical and technological research and SCI - Clyde & Co - October 18th, 2023
- Prognostic Value of Hematogones in Patients With Hematopoietic ... - Cureus - October 18th, 2023
- Stem-Cell Therapy: Filling Gaps in Oro-Maxillofacial Region - Cureus - October 18th, 2023
- The neonatal southern white rhinoceros ovary contains oogonia in ... - Nature.com - October 18th, 2023
- OMG: Sperm injury led to rare baby struggle - news.com.au - October 18th, 2023
Recent Comments